Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q2 2023 Earnings Call Transcript August 8, 2023
Xeris Biopharma Holdings, Inc. misses on earnings expectations. Reported EPS is $-0.14 EPS, expectations were $0.13.
Operator: Good morning all. I would like to welcome you all to Xeris Biopharma Second Quarter 2023 Financial Results Call. My name is [Prika], and I will be your moderator for today’s call. All lines are on mute for the presentation portion of the call today with an opportunity for...
